- Home
- CTXR vs BLNE Comparison
CTXR vs BLNE Comparison
Compare CTXR & BLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- BLNE
- Stock Information
- Founded
- CTXR 2007
- BLNE 2019
- Country
- CTXR United States
- BLNE United States
- Employees
- CTXR N/A
- BLNE N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- BLNE
- Sector
- CTXR Health Care
- BLNE
- Exchange
- CTXR Nasdaq
- BLNE NYSE
- Market Cap
- CTXR 14.6M
- BLNE 11.9M
- IPO Year
- CTXR N/A
- BLNE N/A
- Fundamental
- Price
- CTXR $1.53
- BLNE $1.34
- Analyst Decision
- CTXR Strong Buy
- BLNE
- Analyst Count
- CTXR 3
- BLNE 0
- Target Price
- CTXR $53.00
- BLNE N/A
- AVG Volume (30 Days)
- CTXR 6.7M
- BLNE 5.7M
- Earning Date
- CTXR 08-11-2025
- BLNE 08-13-2025
- Dividend Yield
- CTXR N/A
- BLNE N/A
- EPS Growth
- CTXR N/A
- BLNE N/A
- EPS
- CTXR N/A
- BLNE N/A
- Revenue
- CTXR N/A
- BLNE $5,213,000.00
- Revenue This Year
- CTXR N/A
- BLNE $456.73
- Revenue Next Year
- CTXR N/A
- BLNE $28.26
- P/E Ratio
- CTXR N/A
- BLNE N/A
- Revenue Growth
- CTXR N/A
- BLNE 63.03
- 52 Week Low
- CTXR $0.65
- BLNE $0.62
- 52 Week High
- CTXR $26.25
- BLNE $29.80
- Technical
- Relative Strength Index (RSI)
- CTXR 68.44
- BLNE N/A
- Support Level
- CTXR $0.76
- BLNE N/A
- Resistance Level
- CTXR $1.45
- BLNE N/A
- Average True Range (ATR)
- CTXR 0.31
- BLNE 0.00
- MACD
- CTXR 0.06
- BLNE 0.00
- Stochastic Oscillator
- CTXR 47.63
- BLNE 0.00
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
About BLNE EASTSIDE DISTILLING INC
Beeline Holdings Inc is a technology-driven mortgage lender and title provider building a fully digital, AI-powered platform that simplifies and accelerates the home financing process.